Sunday, August 19, 2018
Editor’s Zone

Editor’s Zone

This space is for the Editor's critical take on the various issues of importance that have happened during the week. The inside review of various initiatives, developments and the news that mattered most. Few a times, its a bitter pill yet next time a sweet candy, the 'Editor's Zone' acts as an applauder, neutral observer and critic depending on the objectivity. Feel free to connect with the Editor at [email protected]

Face to Face

“India will be Cepheid’s first manufacturing site outside US & Europe”

225
In an exclusive face to face interaction with the BioVoice, Mr Peter Farrell, Executive Vice President, Cepheid, and Mr Jai Shankar Krishnan, President & CEO, Danaher India shared the details about their companies' journey in India, TB elimination efforts and manufacturing plans...……..

Chat with BioVoice

“Categorization into phytopharma will encourage use of herbal drugs”

360
Mentioned Mr Amit Sharma, Director, Sanat Products in an exclusive interaction with the BioVoice where he shared details on the company's activities, regulations, outlook and much more...……………..